眼科新进展2017，Vol.37Issue(6)：583-586,4.DOI:10.13389/j.cnki.rao.2017.0148
抗血管内皮生长因子(VEGF)治疗与视网膜下纤维化研究进展
Anti-VEGF therapy and subretinal fibrosis
摘要
Abstract
Subretinal fibrosis contributes to the loss of vision associated with agerelated macular degeneration.Anti-vascular endothelial growth factor therapy is the current standard treatment for exudative age-related macular degeneration.In this review,many risk factors of subretinal fibrosis are discussed,the relationship between anti-vascular endothelial growth factor therapy and subretinal fibrosis,some potential novel therapeutic methods to suppresses subretinal fibrosis are also revealed.关键词
视网膜下纤维化/年龄相关性黄斑变性/抗血管内皮生长因子Key words
subretinal fibrosis/age-related macular degeneration/anti-vascular endothelial growth factor分类
医药卫生引用本文复制引用
吕亚男,宫媛媛..抗血管内皮生长因子(VEGF)治疗与视网膜下纤维化研究进展[J].眼科新进展,2017,37(6):583-586,4.基金项目
国家自然科学基金项目(编号:81300774) （编号:81300774）
上海市自然科学基金项目(编号:12ZR1424500)上海市眼底病重点实验室开放课题基金项目(编号:07Z22911) （编号:12ZR1424500）
National Natural Science Foundation of China (No:81300774) （No:81300774）
Natural Science Foundation of Shanghai (No:12ZR1424500) （No:12ZR1424500）
Open Fund Project in Ocular Founds Disease Key Laboratory of Shanghai (No:07Z22911) （No:07Z22911）
